Back to dashboard
Episode 67
DIP Episode 67 - Psych Pharmacology (Part 1 of 2)
PharmacologyMedium4 - HighHas Q&A
Step 1Step 2Step 3MedicineUSMLEStep 1Step 2Step 3
Topic
Antidepressants (SSRIs, SNRIs, TCAs, MAOIs); Anxiolytics and Hypnotics; Sleep Disorders (Narcolepsy, Insomnia); Psychopharmacology Mechanisms.
Key Takeaway
Understanding the specific mechanisms of action, side effects, and critical drug interactions for major psychotropic classes—especially TCA overdose management, SSRI/SNRI dosing timelines, MAOI dietary restrictions, and distinguishing sleep disorders like narcolepsy from insomnia—is crucial for USMLE success.
Runtime: 34.8 min
Published: 2018-12-31
Completed audio: Yes
Completed notes: Yes
Anki made: Yes
Section: PHARMACOLOGY, PSYCH
Episode Notes
Source / episode info
- Episode: 67
- Title: Divine Intervention Episode 67 – Psych Pharmacology (Part 1 of 2)
- Published: 2018-12-31
- Source: Episode page
One-liner
This episode provides a comprehensive review of psychopharmacology, detailing the mechanisms, side effects, and clinical applications of antidepressants (SSR Is, SNR Is, TC As, MAO Is), anxiolytics (Benzodiazepines/Barbiturates), hypnotics (Z-drugs), and agents for sleep disorders (orexin antagonists).
High-yield summary
- TC As: Block {H}_1, _1, and muscarinic receptors (anticholinergic effects); overdose causes wide-complex QRS complexes due to sodium channel blockade.
- SSR Is/SNR Is: First-line for most psychiatric disorders (MDD, GAD, OCD, PTSD); require 4–6 weeks to reach therapeutic effect; risk of Serotonin Syndrome when combined with other serotonergic agents.
- MAO Is: Non-selective inhibitors ({Phenelzine}, {Tranylcypromine}); contraindicated with high-tyramine diet due to risk of hypertensive crisis, treated by {Phentolamine}.
- Sleep Disorders: Narcolepsy is characterized by low CSF Orexin and excessive daytime sleepiness; insomnia can be managed with orexin receptor antagonists ({Suvorexant}).
- Anxiolysis/Hypnosis: Benzodiazepines increase GABA-A frequency of opening, while Barbiturates increase the duration of GABA-A opening.
Learning objectives
- Differentiate the mechanisms of action and toxicities of TC As, SSR Is, SNR Is, and MAO Is.
- Recognize the clinical presentation and diagnostic workup of primary sleep disorders (Narcolepsy vs. Insomnia).
- Understand critical drug interactions in psychopharmacology, particularly those involving monoamine oxidase inhibitors and dietary tyramine.
- Apply knowledge of anxiolytic agents (Benzodiazepines vs. Barbiturates) regarding receptor binding kinetics and overdose management.
- Identify the appropriate first-line treatment for common psychiatric conditions like Major Depressive Disorder (MDD), Generalized Anxiety Disorder (GAD), and OCD.
Board exam buzzwords
| Condition | Key Finding | Association | Board Exam Tip |
| TCA Overdose | Wide-complex QRS complexes | Sodium channel blockade ({Na}^+) | Remember the classic triad: Anticholinergic effects, {H}_1 sedation, and wide QRS. Treat with {NaHCO}_3. |
| MAOI + Tyramine | Hypertensive Crisis | Inhibition of gut Monoamine Oxidase (MAO) | The mechanism is critical: MAO normally breaks down tyramine; MAO Is prevent this breakdown. Use {Phentolamine} for treatment. |
| Narcolepsy | Low CSF Orexin | Polysomnography/EDS/Cataplexy | Cataplexy (sudden muscle loss) is a hallmark sign, often triggered by strong emotions. |
| Serotonin Syndrome | Myoclonus + Diarrhea + Altered Mental Status | Excessive serotonergic activity (e.g., SSRI + MAOI) | The classic triad: Diarrhea (D), Myoclonus, and altered mental status. Treat with {Benzodiazepines} or Super-hyptodine. |
Rapid review table
| Topic | Key Point | Context | Exam Relevance |
| TC As | Anticholinergic, Sedating, Sodium Channel Blockade | Overdose/Toxicity | High yield: Wide QRS complexes and {NaHCO}_3 treatment. |
| SSR Is | Selective Serotonin Reuptake Inhibition | MDD, GAD, OCD, PTSD | Remember the 4–6 week delay in therapeutic effect; first-line for most common psychiatric disorders. |
| MAO Is | Non-selective MAO-A and MAO-B inhibition | Dietary Tyramine/Hypertensive Crisis | Must avoid tyramine-rich foods (e.g., aged cheese) due to the risk of a life-threatening crisis. |
| Narcolepsy | Low CSF Orexin levels | Excessive Daytime Sleepiness (EDS) with Cataplexy | Diagnosis relies on polysomnography and testing for low orexin/hypocretin. |
Board-speak -> diagnosis
| Board-speak / Vignette phrase | Diagnosis / Concept | Why it fits |
| A patient presents with a history of depression and is started on an SSRI. The physician advises waiting at least four weeks before assessing efficacy or changing the dose. | Antidepressant Onset Delay | SSR Is/SNR Is require 4–6 weeks to reach therapeutic plasma levels, making early assessment misleading. |
| A patient with chronic depression is treated with a drug that blocks {H}_1, _1, and muscarinic receptors. Overdose results in wide-complex QRS complexes. | Tricyclic Antidepressant (TCA) Toxicity | TC As are classic sodium channel blockers, leading to characteristic widened QRS on EKG; the anticholinergic effects cause sedation/confusion. |
| A patient with depression is started on an MAOI and subsequently consumes aged cheese and cured meats. The patient develops a severe hypertensive crisis. | Tyramine Crisis (MAOI Interaction) | MAO Is inhibit gut monoamine oxidase, preventing the breakdown of dietary tyramine, leading to massive sympathetic release. |
| A patient presents with excessive daytime sleepiness, cataplexy, and low CSF levels of orexin. | Narcolepsy | The classic triad (EDS, cataplexy, low Orexin) points directly to narcolepsy; diagnosis requires polysomnography. |
| A patient is being treated for OCD. First-line agents include SSR Is, but the mnemonic D-C-O suggests an alternative agent: Chlorpromazine and Olanzapine. | OCD Treatment Agents | The speaker highlighted this specific association (D/SSR Is -> C/Chlorpromazine -> O/Olanzapine) as a high-yield exam point. |
| A patient with chronic pain is treated with a drug that increases both serotonin and norepinephrine levels, leading to symptomatic relief from fibromyalgia. | SNR Is ({Duloxetine}) | SNR Is increase NE (reducing hyperadrenergic state) and 5-HT, making them effective for neuropathic/fibromyalgia pain. {Duloxetine} is the key agent here. |
Differential diagnosis / distinguishing features
Sleep Disorders: Narcolepsy vs. Insomnia
| Key Features | Distinguishing Findings | Next Step |
| Narcolepsy | Excessive Daytime Sleepiness (EDS), Cataplexy, Low CSF Orexin. | Diagnosis via Polysomnography; treatment with stimulants ({Modafinil}) or Sodium Oxybate. |
| Insomnia | Difficulty initiating/maintaining sleep; often the reverse of narcolepsy's pathophysiology. | Can be treated by orexin receptor antagonists (e.g., {Suvorexant}), which mimic a "wake-promoting" state. |
Anxiolytic Agents: Benzodiazepines vs. Barbiturates
| Key Features | Distinguishing Findings | Next Step |
| Benzodiazepines (e.g., Diazepam) | Increase the frequency of {GABA}_{{A}} receptor opening. | Overdose is reversible with Flumazenil. |
| Barbiturates (e.g., Phenobarbital) | Increase the duration of {GABA}_{{A}} receptor opening. | Overdose is generally refractory/not reversed by Flumazenil; requires supportive care and airway protection. |
Management pearls
- TCA Overdose: Treat with IV Sodium Bicarbonate (\text{NaHCO}_3) to overcome the sodium channel blockade, which helps stabilize the cardiac membrane potential.
- MAOI Hypertensive Crisis: Administer \text{Phentolamine} (a reversible \alpha-blocker) intravenously to rapidly control blood pressure and prevent vascular damage.
- Serotonin Syndrome Management: Initial management involves discontinuing all serotonergic agents, followed by supportive care; Benzodiazepines are used for agitation/myoclonus.
- Acute Psychiatric Crisis (Catatonia): If benzodiazepines fail in a patient with catatonia and refractory depression, ECT is highly effective and safe, even in pregnancy.
Don't miss
🚨
SSR Is Take Time: Never adjust the dose or change the medication for MDD/GAD based on symptoms observed within the first 2–3 weeks; wait at least 4–6 weeks.
🚨
TCA Anticholinergic Effects: These effects (dry mouth, urinary retention, constipation) are a major reason to use caution in elderly patients due to increased risk of confusion and delirium.
🚨
\text{Phentolamine} vs \text{Phenoxybenzamine}: Remember that \text{Phentolamine} is the specific drug used for acute hypertensive crisis management (reversibly blocks \alpha-receptors).
🚨
Chlorpromazine/Olanzapine Mnemonic: For OCD treatment, remember the sequence: SSR Is -> Chlorpromazine -> Olanzapine.
Integration & clinical reasoning
- Pharmacology & Metabolism: The use of MAO Is and the risk of tyramine crisis directly links psychopharmacology to gastrointestinal physiology (gut flora containing MAO) and cardiovascular regulation (\alpha-adrenergic receptors).
- Neurobiology & Sleep: Narcolepsy's pathophysiology involves low orexin, linking sleep disorders to specific neuropeptide deficiencies in the hypothalamus.
- Pharmacology & Emergency Medicine: The management of TCA overdose requires understanding cardiac electrophysiology (sodium channel blockade) and acid-base balance (\text{NaHCO}_3 administration).
OMM / COMLEX integration
🦴
For COMLEX: know these viscerosomatics / Chapman points, but don't let OMM distract from emergent diagnosis and management.
- Acute/Unstable Management: In any acute crisis (e.g., hypertensive emergency from MAOI ingestion, TCA overdose with arrhythmias), standard advanced life support protocols take absolute priority over OMT.
- Clinical Integration: The management of severe psychiatric conditions like catatonia or refractory depression often requires rapid stabilization and may necessitate ECT, which is a procedure that must be managed by the surgical/anesthesia team first.
Concept connections / cross-references
- For a deeper dive into general psychopharmacology mechanisms, review [Episode 66].
- For detailed information on the neurobiology of sleep and wakefulness, see [Episode 70] (Hypothetical future episode number for better structure).
High-yield association table
| Condition | Association | Mechanism | Clinical Significance |
| TCA Overdose | Wide QRS Complex | Sodium channel blockade ({Na}^+) | Requires immediate {NaHCO}_3 administration; life-threatening arrhythmia risk. |
| MAOI + Tyramine | Hypertensive Crisis | Inhibition of gut MAO preventing tyramine breakdown | Dietary restriction is mandatory (tyramine-free diet); emergency treatment with -blockers ({Phentolamine}). |
| Narcolepsy | Low CSF Orexin/Hypocretin | Deficiency in wake-promoting neuropeptides | Diagnosis requires polysomnography; symptoms include excessive daytime sleepiness and cataplexy. |
| Serotonin Syndrome | Myoclonus, Diarrhea, Altered Mental Status | Excessive serotonergic activity (e.g., SSRI + MAOI) | Requires immediate discontinuation of all offending agents and supportive care with {Benzodiazepines}. |
Key terms glossary
| Term | Definition | Context | Example |
| Monoamine Oxidase Inhibitors (MAO Is) | Drugs that inhibit the breakdown of monoamines (Serotonin, NE, Dopamine). | Used for severe depression; high risk due to dietary restrictions. | {Phenelzine}, {Tranylcypromine}. |
| Cataplexy | Sudden, transient loss of muscle tone triggered by strong emotions. | Hallmark symptom of Narcolepsy. | A patient laughing suddenly collapses into a chair. |
| _2 Agonist | Drug that activates _2-adrenergic receptors (inhibitory). | Used to decrease NE release at the synapse, e.g., in opioid withdrawal. | {Clonidine}. |
| Orexin Receptor Antagonist | Drug that blocks orexin receptors, promoting sleep. | Used for insomnia; prevents wake-promoting signals. | {Suvorexant}. |
Study optimization
| Topic | Study Approach | Priority | Resources |
| Antidepressants (Mechanisms) | Create a comparison table: Drug Class -> Mechanism -> Key Side Effect/Toxicity. | High | Review the mnemonic associations ({D-C-O} for OCD; TCA side effects). |
| Sleep Disorders | Focus on pathophysiology and diagnostic testing (CSF levels, Polysomnography). | Medium-High | Contrast Narcolepsy (low Orexin) vs Insomnia (orexin antagonist use). |
| Drug Interactions/Toxicity | Memorize the "Do Not Mix" pairs: MAO Is + Tyramine; SSRI + MAOI; TCA overdose -> wide QRS. | Critical | Use flowcharts for emergency management (e.g., Hypertensive Crisis -> {Phentolamine}). |
Question pattern recognition
- Mechanism of Action: Identifying the specific receptor or enzyme targeted by a drug class (e.g., \alpha_2 agonist vs. \text{MAOI}).
- Toxicity/Overdose Management: Recognizing the unique, life-threatening complication associated with a drug class (e.g., TCA wide QRS).
- Differential Diagnosis: Distinguishing between similar conditions based on specific biomarkers or clinical presentations (e.g., Narcolepsy vs. Insomnia; Primary AI vs. Secondary AI).
Test yourself
Common mistakes to avoid
🚫
Mistake 1: Assuming all psych meds are safe. Never assume a drug is benign; always check for specific side effects, especially anticholinergic burden in the elderly.
🚫
Mistake 2: Confusing RTA types with psychoactive drugs. Do not confuse the mechanisms of \text{Na}^+/\text{H}^+ exchange (PTH/Ang II) with neurotransmitter reuptake inhibition.
🚫
Mistake 3: Overlooking the time delay for SSR Is. Failing to wait 4–6 weeks before adjusting an SSRI dose is a common clinical error and exam trap.
Common traps
⚠️
Trap 1: The "All Drugs" Trap: Assuming that because a drug class (e.g., TCA) has one side effect, all drugs in that class share it equally or are safe to use broadly.
⚠️
Trap 2: Anticholinergic Confusion: Confusing the anticholinergic effects of TC As with other agents; remember the classic triad (\text{H}_1, \alpha_1, muscarinic blockade).
⚠️
Trap 3: The "First Line" Trap: Assuming that because SSR Is are first-line for MDD, they are first-line for every psychiatric disorder (e.g., GAD, OCD, PTSD), ignoring specific agents like \text{Chlorpromazine} or \text{Olanzapine}.